StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)

Close on Nov 18, 2026Market cap $43.89MP/E –Yield –

PDS Biotechnology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

PDS Biotechnology's pe ratio was 39.1× on Oct 31, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Oct 31, 201939.1×–

More PDS Biotechnology figures

See a number that looks wrong?